Department of Biomedical Engineering (M.Z., Y.N., Y.W., W.B., A.V.B., Y.Z., G.P.W., J.Z.), the University of Alabama at Birmingham.
Division of Cardiology, Department of Medicine (Y.C., M.X., G.P.W., J.Z.), the University of Alabama at Birmingham.
Circulation. 2021 Jul 20;144(3):210-228. doi: 10.1161/CIRCULATIONAHA.120.049497. Epub 2021 May 6.
Human induced pluripotent stem cells with normal (wild-type) or upregulated (overexpressed) levels of CCND2 (cyclin D2) expression were differentiated into cardiomyocytes (CCND2CMs or CCND2CMs, respectively) and injected into infarcted pig hearts.
Acute myocardial infarction was induced by a 60-minute occlusion of the left anterior descending coronary artery. Immediately after reperfusion, CCND2CMs or CCND2CMs (3×10 cells each) or an equivalent volume of the delivery vehicle was injected around the infarct border zone area.
The number of the engrafted CCND2CMs exceeded that of the engrafted CCND2CMs from 6- to 8-fold, rising from 1 week to 4 weeks after implantation. In contrast to the treatment with the CCND2CMs or the delivery vehicle, the administration of CCND2CM was associated with significantly improved left ventricular function, as revealed by magnetic resonance imaging. This correlated with reduction of infarct size, fibrosis, ventricular hypertrophy, and cardiomyocyte apoptosis, and increase of vascular density and arterial density, as per histologic analysis of the treated hearts. Expression of cell proliferation markers (eg, Ki67, phosphorylated histone 3, and Aurora B kinase) was also significantly upregulated in the recipient cardiomyocytes from the CCND2CM-treated than from the CCND2CM-treated pigs. The cell proliferation rate and the hypoxia tolerance measured in cultured human induced pluripotent stem cell cardiomyocytes were significantly greater after treatment with exosomes isolated from the CCND2CMs (CCND2Exos) than from the CCND2CMs (CCND2Exos). As demonstrated by our study, CCND2Exos can also promote the proliferation activity of postnatal rat and adult mouse cardiomyocytes. A bulk miRNA sequencing analysis of CCND2Exos versus CCND2Exos identified 206 and 91 miRNAs that were significantly upregulated and downregulated, respectively. Gene ontology enrichment analysis identified significant differences in the expression profiles of miRNAs from various functional categories and pathways, including miRNAs implicated in cell-cycle checkpoints (G2/M and G1/S transitions), or the mechanism of cytokinesis.
We demonstrated that enhanced potency of CCND2CMs promoted myocyte proliferation in both grafts and recipient tissue in a large mammal acute myocardial infarction model. These results suggest that CCND2CMs transplantation may be a potential therapeutic strategy for the repair of infarcted hearts.
具有正常(野生型)或过表达(过表达)水平 CCND2(细胞周期蛋白 D2)表达的人诱导多能干细胞被分化为心肌细胞(CCND2CMs 或 CCND2CMs),并注入梗死猪的心脏。
通过左前降支冠状动脉 60 分钟闭塞诱导急性心肌梗死。再灌注后立即将 CCND2CMs 或 CCND2CMs(每个 3×10 个细胞)或等量的递送载体注射到梗死边界区周围。
从植入后 1 周到 4 周,植入的 CCND2CMs 的数量超过植入的 CCND2CMs 的数量,增加了 6-8 倍。与 CCND2CMs 或递送载体的治疗相比,CCND2CM 的给药与通过磁共振成像显示的左心室功能显著改善相关。这与梗死面积、纤维化、心室肥厚和心肌细胞凋亡的减少以及血管密度和动脉密度的增加相关,这是通过对接受治疗的心脏进行组织学分析得出的。在接受 CCND2CM 治疗的受者心肌细胞中,细胞增殖标志物(例如,Ki67、磷酸化组蛋白 3 和 Aurora B 激酶)的表达也显著上调。从 CCND2CMs(CCND2Exos)分离的外体处理后,在培养的人诱导多能干细胞心肌细胞中测量的细胞增殖率和缺氧耐受性也显著高于从 CCND2CMs(CCND2Exos)处理的细胞。我们的研究表明,CCND2Exos 还可以促进出生后大鼠和成年小鼠心肌细胞的增殖活性。对 CCND2Exos 与 CCND2Exos 的大量 miRNA 测序分析鉴定出分别显著上调和下调的 206 和 91 个 miRNA。基因本体富集分析确定了 miRNA 表达谱在各种功能类别和途径中的显著差异,包括涉及细胞周期检查点(G2/M 和 G1/S 转换)或胞质分裂机制的 miRNA。
我们证明了 CCND2CMs 效力的增强促进了大型哺乳动物急性心肌梗死模型中移植物和受者组织中的心肌细胞增殖。这些结果表明,CCND2CMs 移植可能是修复梗死心脏的一种潜在治疗策略。